MedPath

Teva Pharmaceuticals, Inc.

Teva Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1900-01-01
Employees
10K
Market Cap
-
Website
https://www.tevausa.com

Clinical Trials

7

Active:5
Completed:2

Trial Phases

2 Phases

Phase 1:5
Phase 3:2

Drug Approvals

37

FDA:37

Drug Approvals

Topiramate

Approval Date
Apr 30, 2025
FDA

Ticagrelor

Approval Date
Dec 20, 2024
FDA

Phentermine and topiramate

Approval Date
Feb 28, 2024
FDA

ALVAIZ

Approval Date
Feb 13, 2024
FDA

Plerixafor

Approval Date
Jan 1, 2024
FDA

Pitavastatin

Approval Date
Dec 10, 2023
FDA

Theophylline

Approval Date
Dec 4, 2023
FDA

Nora BE

Approval Date
Oct 31, 2023
FDA

Fingolimod

Approval Date
Oct 1, 2023
FDA

Mycophenolate Mofetil

Approval Date
Aug 30, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 3
2 (28.6%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.